Sector
PharmaceuticalsOpen
₹231.98Prev. Close
₹230.22Turnover(Lac.)
₹6.52Day's High
₹231.98Day's Low
₹223.0152 Week's High
₹274.7552 Week's Low
₹164Book Value
₹162.35Face Value
₹10Mkt Cap (₹ Cr.)
231.45P/E
34.29EPS
6.49Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 9.33 | 9.28 | 7.01 | 6.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 122.53 | 114.78 | 76.04 | 55.9 |
Net Worth | 131.86 | 124.06 | 83.05 | 62.13 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 79.51 | 61.55 | 54.75 | 53.64 |
yoy growth (%) | 29.17 | 12.41 | 2.07 | -13.55 |
Raw materials | -37.42 | -28.03 | -23.8 | -24.22 |
As % of sales | 47.07 | 45.53 | 43.47 | 45.15 |
Employee costs | -8.04 | -6.99 | -6.2 | -5.96 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 7.01 | 1.37 | 1.68 | 0.9 |
Depreciation | -4.3 | -4.12 | -4.33 | -4.31 |
Tax paid | -2.24 | -0.51 | -0.57 | 0.31 |
Working capital | 7.22 | -0.8 | 0.64 | -0.44 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 29.17 | 12.41 | 2.07 | -13.55 |
Op profit growth | 106.65 | -1.93 | 8.47 | -47.49 |
EBIT growth | 245.43 | 12.95 | 27.61 | -77.4 |
Net profit growth | 710.1 | -22.82 | 76.96 | -85.52 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 169.21 | 155.42 | 172.37 | 135.07 | 79.51 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 169.21 | 155.42 | 172.37 | 135.07 | 79.51 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.7 | 1.94 | 0.57 | 1.01 | 2.91 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,687.8 | 94.61 | 4,05,175.7 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,667 | 80.16 | 1,77,075.51 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,505.2 | 24.69 | 1,21,589.7 | 1,485.4 | 1.06 | 4,254.47 | 397.42 |
Dr Reddys Laboratories Ltd DRREDDY | 1,362.5 | 21.24 | 1,13,614.8 | 1,200.7 | 0.59 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,252.5 | 57.74 | 1,10,018.59 | 474 | 0.98 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Laxminarayan Moondra
Whole-time Director
Satyanarayan Mundra
Chairman & Independent Directo
C P Rangachar
Managing Director
Sunil L Mundra
Non Executive Director
Sushil Kumar Mundra
Non Executive Director
Jyothi Mundra
Independent Director
Pramod Kasat
Independent Director
Shirish Gundopant Belapure
Independent Director
T Y Prabhu
Trident Towers 4th Floor No 23,
100Feet Road Jayanagar IIBlock,
Karnataka - 560011
Tel: 91-080-26671571/26671573/26671581
Website: http://www.naturalcapsules.com
Email: company.sec@naturalcapsules.com; info@naturalcapsu
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: investor@cameoindia.com
Summary
Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore. The Company is one of the leading manufacturers of hard capsule shells in India. The Company intro...
Read More
Reports by Natural Capsules Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.